240 related articles for article (PubMed ID: 27993111)
1. Targeting Legumain As a Novel Therapeutic Strategy in Cancers.
Mai CW; Chung FF; Leong CO
Curr Drug Targets; 2017; 18(11):1259-1268. PubMed ID: 27993111
[TBL] [Abstract][Full Text] [Related]
2. An Overview of Targeting Legumain for Inhibiting Cancers.
Reddy BD; Beeraka NM; Chitturi CMK; Madhunapantula SV
Curr Pharm Des; 2021 Oct; 27(31):3337-3348. PubMed ID: 33238867
[TBL] [Abstract][Full Text] [Related]
3. MiRNA-3978 regulates peritoneal gastric cancer metastasis by targeting legumain.
Zhang Y; Wu YY; Jiang JN; Liu XS; Ji FJ; Fang XD
Oncotarget; 2016 Dec; 7(50):83223-83230. PubMed ID: 27793040
[TBL] [Abstract][Full Text] [Related]
4. A novel antitumor prodrug platform designed to be cleaved by the endoprotease legumain.
Stern L; Perry R; Ofek P; Many A; Shabat D; Satchi-Fainaro R
Bioconjug Chem; 2009 Mar; 20(3):500-10. PubMed ID: 19196156
[TBL] [Abstract][Full Text] [Related]
5. Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms.
Wu W; Luo Y; Sun C; Liu Y; Kuo P; Varga J; Xiang R; Reisfeld R; Janda KD; Edgington TS; Liu C
Cancer Res; 2006 Jan; 66(2):970-80. PubMed ID: 16424032
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of CXC chemokines and their receptors in cancer.
Vinader V; Afarinkia K
Future Med Chem; 2012 May; 4(7):853-67. PubMed ID: 22571611
[TBL] [Abstract][Full Text] [Related]
7. Role of LGMN in tumor development and its progression and connection with the tumor microenvironment.
Khan SU; Khan IM; Khan MU; Ud Din MA; Khan MZ; Khan NM; Liu Y
Front Mol Biosci; 2023; 10():1121964. PubMed ID: 36825203
[TBL] [Abstract][Full Text] [Related]
8. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
10. Clinical development of cancer therapeutics that target metabolism.
Clem BF; O'Neal J; Klarer AC; Telang S; Chesney J
QJM; 2016 Jun; 109(6):367-72. PubMed ID: 26428335
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
Xia Y; Choi HK; Lee K
Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
[TBL] [Abstract][Full Text] [Related]
12. The tumor microenvironment: a target for combination therapy of breast cancer.
Reisfeld RA
Crit Rev Oncog; 2013; 18(1-2):115-33. PubMed ID: 23237555
[TBL] [Abstract][Full Text] [Related]
13. Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets.
Szebeni GJ; Vizler C; Nagy LI; Kitajka K; Puskas LG
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886105
[TBL] [Abstract][Full Text] [Related]
14. Legumain: a potential biomarker for atherosclerosis.
Ke BY; Qin YS; Cheng L; Wang SZ
J Pharm Pharmacol; 2023 Nov; 75(11):1395-1404. PubMed ID: 37584490
[TBL] [Abstract][Full Text] [Related]
15. Analysis of legumain and cystatin 6 expression at the maternal-fetal interface in pigs.
Shim J; Seo H; Choi Y; Yoo I; Lee CK; Hyun SH; Lee E; Ka H
Mol Reprod Dev; 2013 Jul; 80(7):570-80. PubMed ID: 23686917
[TBL] [Abstract][Full Text] [Related]
16. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
[TBL] [Abstract][Full Text] [Related]
17. Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis.
Lin Y; Wei C; Liu Y; Qiu Y; Liu C; Guo F
Cancer Sci; 2013 Sep; 104(9):1217-25. PubMed ID: 23691974
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Potential of Small Molecule Inhibitors.
Khera N; Rajput S
J Cell Biochem; 2017 May; 118(5):959-961. PubMed ID: 27813176
[TBL] [Abstract][Full Text] [Related]
19. High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targeting.
Haugen MH; Boye K; Nesland JM; Pettersen SJ; Egeland EV; Tamhane T; Brix K; Maelandsmo GM; Flatmark K
Eur J Cancer; 2015 Jan; 51(1):9-17. PubMed ID: 25466510
[TBL] [Abstract][Full Text] [Related]
20. Targeting Eph/ephrin system in cancer therapy.
Lodola A; Giorgio C; Incerti M; Zanotti I; Tognolini M
Eur J Med Chem; 2017 Dec; 142():152-162. PubMed ID: 28780190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
